• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/9

Click to flip

9 Cards in this Set

  • Front
  • Back
Fungal infections
become increasingly important in bone marrow
transplant ... when
Fungal infections 7 days
herpes virus- 2 weeks
gram negative( Klebs. E coli ) - 3 weeks
staph aur - 3 weeks
who are
at high risk of infection by organisms such as
Candida and Aspergillus.
Patients with graft-versus-host disease
who require long-term immunosuppression are
at high risk of infection by organisms such as
Candida and Aspergillus.

Fungal infections 7 days
herpes virus- 2 weeks
gram negative( Klebs. E coli ) - 3 weeks
staph aur - 3 weeks
These infections can
occur even after engraftment and resolution of
neutropenia... when
Fungal infections 7 days
herpes virus- 2 weeks
gram negative( Klebs. E coli , pseudomona) - 3 weeks
staph aur - 3 weeks
45 days-

cytomegaloviral
pneumonia, parasitic infection,
and human herpes virus 6 infection of the skin
and mucous membranes.
The risk of bacterial infection
is high for bone marrow transplant patients.. when and what bugs
Fungal infections 7 days
herpes virus- 2 weeks
gram negative( Klebs. E coli , pseudomona) - 3 weeks
staph aur - 3 weeks
45 days-

cytomegaloviral
pneumonia, parasitic infection,
and human herpes virus 6 infection of the skin
and mucous membranes.

bacterial infections-
in the first 20–30 days following transplant.
This is due to the 1 to 4 weeks of
neutropenia that follows the transplantation
and renders patients susceptible to aerobic
bacteria found in the gut and on the skin.
what bug is a concern during the
30–90 days after transplantation.
Infection
with Nocardia is a concern during the
30–90 days after transplantation.
Infections
with Staphylococcus aureus are generally limited
to the... when
Infections
with Staphylococcus aureus are generally limited
to the pre-engraftment period 1–3 weeks
posttransplant. This type of infection would
not be expected in a patient 45 days posttransplant
Patients are most at
risk for gram-negative bacteremia in ....when an d what bug
Patients are most at
risk for gram-negative bacteremia in the 1–3
weeks following transplant. These infections
are usually caused by intestinal flora such as
Escherichia coli, Pseudomonas, and Klebsiella.

Answer D is incorrect. Patients being treated
for hematogenous malignancy are indeed at
increased risk of Pneumocystis carinii pneumonia.
However, they are treated with trimethoprim-
sulfamethoxazole prophylaxis, which prevents
100% of cases when taken correctly.
Provided this patient has been compliant with
her medications as stated, her risk of acquiring
this disease is quite low.
Answer E is incorrect. The risk of herpes simplex
virus (HSV) reactivation is highest in the
2 weeks following transplant. It causes severe
mucositis that has been shown to occur with
lower incidence if HSV-seropositive patients
are treated with prophylactic acyclovir.
Answer F is incorrect. Patients with
Hodgkin’s disease are at an unexplained increased
risk for Salmonella infection. No such
known risk exists for patients with promyelocytic
leukemia
The risk of herpes simplex
virus (HSV) reactivation is highest in ,,, when
The risk of herpes simplex
virus (HSV) reactivation is highest in the
2 weeks following transplant. It causes severe
mucositis that has been shown to occur with
lower incidence if HSV-seropositive patients
are treated with prophylactic acyclovir.
Patients with
Hodgkin’s disease are at an unexplained increased
risk
Patients with
Hodgkin’s disease are at an unexplained increased
risk for Salmonella infection. No such
known risk exists for patients with promyelocytic
leukemia